Advertisement
Lynparza (olaparib) targets mutations found in about 30 percent of men with prostate cancer

Ovarian Cancer Rx Promising for Prostate Tumors

0
In small study, olaparib targeted gene mutation in men who had failed other therapy
The melanoma drug Yervoy (ipilimumab) can now be used to reduce the risk of the recurrence after surgery

FDA Approves Expanded Use for Melanoma Drug

0
Yervoy can now be used after surgery to reduce risk of skin cancer returning
Human papillomavirus vaccination rates among American girls remain too low

CDC: Not Enough Young Girls Getting HPV Vaccination

0
Need to increase delivery of the vaccine at the recommended ages of 11 or 12 years
Hidradenitis suppurativa can be associated with infectious and/or neoplastic fatal complications

Fatal Case of Hidradenitis Suppurativa Described

0
Case report describes fatal case of HS associated with sepsis and squamous cell carcinoma
A considerable proportion of federal marketplace plans lack at least one in-network specialist

Nearly 15 Percent of Plans Lack In-Network Specialists

0
Most commonly excluded specialists are in endocrinology, rheumatology, and psychiatry
For patients enrolled in metastatic colorectal cancer trials

Low BMI Linked to Increased Risk of Progression, Death in mCRC

0
Risk of progression and/or death highest for low BMI, decreases as BMI increases, then plateaus
Among women with breast cancer and silicone implant reconstruction

Internal Mammary Lymph Nodes ID’d on MRI Likely to Be Benign

0
Findings in IMLNs ID'd at implant-protocol breast MRI after oncoplastic surgery for breast cancer
Imlygic (talimogene laherparepvec) has been approved by the U.S. Food and Drug Administration to treat melanoma lesions of the skin and lymph nodes.

FDA Approves Imlygic for Melanoma

0
Injectable drug designed to rupture and kill cancer cells
Nearly 13 percent of American adults have tried electronic cigarettes at least once

CDC: E-Cigarette Use Highest Among 18- to 24-Year-Olds

0
Almost 4 percent of all adult Americans use them, new survey shows
For patients with oropharyngeal squamous cell carcinoma

Transoral Robotic Surgery Feasible for Oropharyngeal SCC

0
Results encouraging, with clear margins in 33 of 35 patients; 13 patients spared from adjuvant tx